Snap!

“She thought it was the misfortune of poetry to be seldom safely enjoyed by those who enjoyed it completely; and that the strong feelings which alone could estimate it truly were the very feelings which ought to taste it but sparingly." -Jane Austen

Stay in the know!

Oct 15: Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era



Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era

a roundtable discussion with Beatriz Preciado, and José Muñoz & Avital Ronell

Tuesday, October 15
6:30 to 8 pm

Beatriz Preciado, History of the Body, Gender Theory, and History of Performance, University of Paris 8

José Muñoz, Performance Studies, New York University

Avital Ronell, Comparative Literature and German, New York University

“If the reader sees this text as an uninterrupted series of philosophical reflections, accounts of hormone administration, and detailed records of sexual practices without the solutions provided by continuity, it is simply because this is the mode on which subjectivity is constructed and deconstructed.”  So concludes the Introduction to Beatriz Preciado’s Testo Junkie.  The book blurs boundaries — between high theory and diaristic self-portraiture  – and explodes disciplinary conventions in a path-breaking examination of the impact of new technologies and representational forms on the way sex, sexuality, gender, and “the” body are lived and experienced.   This forum puts author Beatriz Preciado into conversation with José Muñoz and Avital Ronell on the occasion of Testo Junkie’s first publication in English.

Department of Performance Studies
721 Broadway, 6th Floor, Room 612

For more information about this event, please contact CSGS at csgs(at)nyu.edu or 212-992-9540.

Venue is wheelchair accessible.

Facebook event page here.

Co-sponsored by the NYU Center for the Study of Gender & Sexuality and the Department of Performance Studies.



Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • LinkedIn
  • MySpace
  • RSS
  • Twitter
  • Yahoo! Buzz

Comments are closed.